We are live on
!
Find out more
Barrow, Hanley, Mewhinney & Strauss Portfolio holdings
AUM
$30.5B
1-Year Est. Return
29.95%
This Fund
S&P 500
This Quarter
Est. Return
+3.22%
1 Year Est. Return
+29.95%
3 Year Est. Return
+81.25%
5 Year Est. Return
+106.98%
10 Year Est. Return
+342.87%
AUM
$65.7B
AUM Growth
+$262M
(+0.4%)
Cap. Flow
-$1.29B
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
26.53%
Holding
362
New
36
Increased
82
Reduced
200
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$713M |
| 2 |
Cardinal Health
CAH
|
+$533M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$358M |
| 4 |
Fidelity National Financial
FNF
|
+$181M |
| 5 |
Elevance Health
ELV
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$518M |
| 2 |
Entergy
ETR
|
+$423M |
| 3 |
Honeywell
HON
|
+$287M |
| 4 |
CenterPoint Energy
CNP
|
+$264M |
| 5 |
Johnson & Johnson
JNJ
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.02% |
| 2 | Healthcare | 19.84% |
| 3 | Industrials | 14.73% |
| 4 | Energy | 11.33% |
| 5 | Technology | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
ICF International
ICFI
$1.72B
| $1.09M | ﹤0.01% |
26,724
-4,081
| -13% | -$160K |
|
|
SF
277
Stifel
SF
$12.6B
| $1.09M | ﹤0.01% |
78,084
+15,926
| +26% | +$237K |
|
278
America's Car Mart
CRMT
$26.9M
| $1.08M | ﹤0.01% |
38,408
-7,185
| -16% | -$178K |
|
|
XXIA
279
DELISTED
Ixia
XXIA
| $1.08M | ﹤0.01% |
+110,460
| New | +$1.13M |
|
280
McGrath RentCorp
MGRC
$2.92B
| $1.08M | ﹤0.01% |
+35,433
| New | +$956K |
|
|
RAVN
281
DELISTED
Raven Industries Inc
RAVN
| $1.08M | ﹤0.01% |
+56,854
| New | +$994K |
|
282
Onto Innovation
ONTO
$15.3B
| $1.06M | ﹤0.01% |
50,796
+19,242
| +61% | +$340K |
|
283
Digi International
DGII
$3.1B
| $1.02M | ﹤0.01% |
94,696
+17,319
| +22% | +$179K |
|
284
ExxonMobil
XOM
$634B
| $1M | ﹤0.01% |
10,700
| – | – |
|
285
Evertec
EVTC
$1.78B
| $971K | ﹤0.01% |
+62,424
| New | +$902K |
|
|
TMHC
286
DELISTED
Taylor Morrison
TMHC
| $961K | ﹤0.01% |
+64,768
| New | +$953K |
|
|
CKH
287
DELISTED
Seacor Holdings Inc.
CKH
| $941K | ﹤0.01% |
16,796
-66
| -0.4% | -$3.63K |
|
|
PDLI
288
DELISTED
PDL BioPharma, Inc.
PDLI
| $933K | ﹤0.01% |
297,175
-1,068
| -0.4% | -$3.56K |
|
289
Arcos Dorados Holdings
ARCO
$1.74B
| $929K | ﹤0.01% |
200,251
+36,693
| +22% | +$156K |
|
290
Andersons Inc
ANDE
$2.22B
| $902K | ﹤0.01% |
25,393
-89
| -0.3% | -$2.91K |
|
291
Belden
BDC
$5.19B
| $891K | ﹤0.01% |
+14,760
| New | +$923K |
|
|
AXLL
292
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $866K | ﹤0.01% |
26,565
-11,980
| -31% | -$304K |
|
293
Rush Enterprises Class A
RUSHA
$6.22B
| $835K | ﹤0.01% |
87,174
-317
| -0.4% | -$2.81K |
|
294
Grupo Cibest SA
CIB
$21.1B
| $769K | ﹤0.01% |
22,030
+4,000
| +22% | +$142K |
|
295
LivePerson
LPSN
$32.3M
| $732K | ﹤0.01% |
7,700
-4,393
| -36% | -$420K |
|
296
Chefs' Warehouse
CHEF
$4.5B
| $722K | ﹤0.01% |
45,164
-104
| -0.2% | -$1.77K |
|
297
Copa Holdings
CPA
$5.8B
| $700K | ﹤0.01% |
13,401
+3,350
| +33% | +$193K |
|
|
ENIA
298
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $673K | ﹤0.01% |
+78,360
| New | +$624K |
|
299
Shinhan Financial Group
SHG
$35.6B
| $653K | ﹤0.01% |
19,960
+1,700
| +9% | +$58.3K |
|
300
V2X
VVX
$2.65B
| $585K | ﹤0.01% |
20,534
+6,533
| +47% | +$157K |
|
Similar funds
Barrow, Hanley, Mewhinney & Strauss's Q2 2016 Portfolio in Review
As of Q2 2016, Barrow, Hanley, Mewhinney & Strauss held 362 positions worth $65.7B, up 0.4% from $65.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barrow, Hanley, Mewhinney & Strauss's Q2 2016 filing shows 36 new, 82 increased, 200 reduced and 39 closed positions. Its largest new stake was Fidelity National Financial: 7,688,148 shares worth $200M. The largest sale was Medtronic, an estimated $518M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.
- Barrow, Hanley, Mewhinney & Strauss's largest Q2 2016 buy was Fidelity National Financial: 7,688,148 shares worth $200M.
- Barrow, Hanley, Mewhinney & Strauss added most to Teva Pharmaceuticals in Q2 2016, an estimated $713M increase.
- Barrow, Hanley, Mewhinney & Strauss's biggest Q2 2016 reduction was Medtronic, cutting an estimated $518M.
- Barrow, Hanley, Mewhinney & Strauss fully exited People's United Financial Inc in Q2 2016, selling an estimated $180M.
- Barrow, Hanley, Mewhinney & Strauss's ten largest holdings make up 27% of its $65.7B portfolio in Q2 2016.
- Barrow, Hanley, Mewhinney & Strauss opened 36 new positions and closed 39 in Q2 2016.
- Barrow, Hanley, Mewhinney & Strauss's portfolio value rose 0.4% quarter-over-quarter to $65.7B.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2016, filed 8 Aug 2016.